Document is current
Any future updates will be listed below
-
Authors
Sperb, Nadine
Maksakova, Irina A. https://orcid.org/0009-0008-0792-873X
Escano, Leo
Abraham, Libin
MacPhee, Liam
Cabantog, Ariene
Kim, Dexter https://orcid.org/0009-0000-7363-1522
Yu, Mansen https://orcid.org/0000-0002-1353-4154
Krowiorz, Kathrin
Im, Junbum
Grasedieck, Sarah https://orcid.org/0000-0002-8721-5295
Pochert, Nicole
Ruess, Christoph
Rösler, Reinhild
Flibotte, Stephane
Maetzig, Tobias https://orcid.org/0000-0001-8259-3150
Calzia, Enrico
Palmqvist, Lars https://orcid.org/0000-0001-9274-360X
Wiese, Sebastian https://orcid.org/0000-0001-5697-2608
Fogelstrand, Linda https://orcid.org/0000-0003-3698-8519
Gold, Michael R.
Rouhi, Arefeh https://orcid.org/0000-0002-6450-027X
Kuchenbauer, Florian https://orcid.org/0000-0002-9820-3409
-
Funding
Funding for this research was provided by:
Deutsche Krebshilfe (109420)
European Hematology Association (2010/04)
Deutsche Forschungsgemeinschaft (SFB 1074, Project A5, SFB 1074, Project A5, Gender Equality Program, SFB 1074, Project Z2)
Wilhelm Sander-Stiftung (215.153.1)
Leukemia and Lymphoma Society of Canada
International Graduate School of Molecular Medicine, Ulm University, Germany
Gouvernement du Canada | Canadian Institutes of Health Research (PJT-166196, PJT 166196)
Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (AWD-010517, AWD 010517)
International Graduate School of Molecular Medicine, Ulm University, Germany.
Cancerfonden (CAN2014/525)
Barncancerfonden (PR214-0125)
Västra Götalandsregionen
Baustein Startförderung Program of the Medical Faculty, Ulm University
- License Information
-
More Information
Article History
Received: 30 August 2024
Revised: 10 January 2025
Accepted: 28 February 2025
First Online: 17 March 2025
Competing interests
: The authors declare no competing interests.
: All methods were performed in accordance with the relevant guidelines and regulations. Animal experiments with H9M and H9M cells were approved by the state government of Tübingen, Germany. Animal experiments with OCIAML3 cells were performed according to animal research protocol # A19-0320 approved by the University of British Columbia Animal Care and Use Committee. All patients provided informed consent under protocols approved by the Regional Ethical Review Board in Gothenburg.
